Idt Australia Limited. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Idt Australia Limited. with three other
companies in this sector in AUSTRALIA :
sales of 13.94 million Australian Dollars [US$10.76 million]
of which 99%
was Cancer Immunotherapy),
(12.55 million Australian Dollars [US$9.69 million]
of which 56%
was Mannitol), and
(7.48 million Australian Dollars [US$5.78 million]
of which 79%
was Advangen Japan).
Idt Australia Limited. reported sales of A$14.17 million (US$10.94 million)
June of 2020.
increase of 16.8%
versus 2019, when the company's sales were A$12.13 million.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Idt Australia Limited. had sales
of A$15.72 million.